Aker Biomarine AS
Research Aker Biomarine AS (AKBM) on Bullrun: market cap NOK 10.89B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAKBM
- ExchangeOL
- CountryNorway
- SectorConsumer Defensive
- IndustryPackaged Foods
- CurrencyNOK
- Market capNOK 10.89B
- Financial periodFY2025
- RevenueUSD 218.10M
- Revenue growth9.6%
- Net income-USD 22.80M
- Free cash flow-USD 4.90M
- Gross margin44.8%
Valuation Snapshot
latest market cap is NOK 10.89B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 218.10M | -USD 22.80M | -USD 4.90M | 44.8% | -0.26 | USD 16.40M | USD 182.10M | USD 144.00M |
| FY2024 | USD 199.00M | USD 180.30M | -USD 5.20M | 34.7% | -0.16 | USD 15.00M | USD 147.50M | USD 173.90M |
| FY2023 | USD 196.30M | -USD 9.00M | USD 1.50M | 36.9% | -0.36 | USD 27.50M | USD 393.00M | USD 366.50M |
| FY2022 | USD 277.20M | USD 10.00M | -USD 25.40M | 41.4% | 0.11 | USD 22.30M | USD 381.20M | USD 378.70M |
| FY2021 | USD 262.10M | -USD 8.00M | -USD 76.10M | 33.6% | -0.09 | USD 11.10M | USD 324.80M | USD 370.50M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | NOK 10.89B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 NOK.
| Year | Dividends/share |
|---|---|
| FY2024 | 45 USD |
About Aker Biomarine AS
Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. It operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business. The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LYSOVETA brand;
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is Aker Biomarine AS's market cap?
Aker Biomarine AS's market capitalization is NOK 10.89B.
What does Aker Biomarine AS do?
Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. It operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business. The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LYSOVETA brand; and marine-origin DHA omega-3 from microalgae under the Revervia brand name, as well as advanced phospholipid technology under PL+ name.